Last updated: June 2026. NAD+ and NMN are sold as dietary supplements and, in clinical settings, prepared as compounded medications. The human evidence behind both is limited. Every claim below links to a primary source you can open and read yourself.
Here’s the confusion that trips up almost everyone who starts one of these: there isn’t one clock running when you begin NAD+ or NMN. There are at least three, and they move at completely different speeds. One is a lab marker in your blood. One is whatever your body actually feels like on a Tuesday. One is the marketing promise, and it usually moves fastest of all, which is precisely the problem.
Mixing those three up is what causes most of the disappointment people report after a few weeks. So before getting into a week-by-week picture, it helps to separate them clearly, because the gap between “the marker moved” and “I felt something” is exactly where realistic expectations live.
What “results” actually means before any of this starts
NAD+ is a molecule cells genuinely depend on, and it does decline with age. That much isn’t marketing spin. A 2012 study measured NAD+ in human skin from newborns up through age 77 and found a steady decline in both men and women [P5]. NMN is the oral building block the body converts into NAD+ [P1]; NAD+ itself is the finished coenzyme [P4].
The part that gets left out of most sales copy: nobody has shown that topping the level back up makes a person feel younger or live longer. A major review of NAD+ biology is direct about this, stating that whether restoring NAD+ in aging humans actually helps remains unknown [P4]. So a “results timeline” here isn’t a countdown to a guaranteed transformation. It’s a description of what the limited evidence suggests might happen, clearly separated from what is simply hoped for.
Clock one: the lab marker (weeks one to two)
This is the fastest-moving clock, and it’s the one most people don’t have access to unless they’re getting tested.
In the first week or two, a rising NAD+ marker is plausible if someone is taking an oral precursor. A 2018 placebo-controlled trial of nicotinamide riboside, a close relative of NMN, showed chronic dosing reliably raised NAD+ levels in healthy middle-aged and older adults [P3]. That’s real, and it happens early.
What it is not, though, is a feeling. A number on a lab report can be climbing steadily while daily life feels exactly the same as before. If the first two weeks feel unremarkable, that isn’t failure. It’s the marker clock doing its quiet work while the felt-experience clock hasn’t caught up, if it ever does.
Clock two: the felt experience (weeks three to ten, and it’s specific)
This is where the actual human trials lived, so this is the stretch worth paying attention to, with realistic expectations attached.
The strongest result on record ran ten weeks. In a 2021 Science study, postmenopausal women with prediabetes took 250 mg of NMN daily, and by the end the treatment group showed measurably better muscle insulin sensitivity [P1]. That’s a genuine, measurable effect. It’s also the kind of effect that shows up on a test, not in how the day feels.
A second trial is a useful check on enthusiasm. When researchers gave NMN to amateur runners in 2021, some submaximal aerobic markers improved, but VO2max, the headline measure of aerobic fitness, did not change [P2]. Some narrow numbers moved. The big one didn’t. A runner in that study likely wouldn’t have noticed a clear difference either way.
So through this window: some people report steadier energy or better recovery, and that’s worth tracking. But the proven effects so far are specific, lab-measured outcomes in particular groups [P1][P2], not a guaranteed subjective lift. Feeling better is a bonus the evidence doesn’t promise. Feeling nothing in particular isn’t a sign anything went wrong.
Clock three: the marketing promise (same-day, and mostly unsupported)
This is the clock that moves fastest and is backed by the least.
IV clinics often suggest a visitor will walk out noticeably different. The honest picture is less flattering. A 2026 systematic review searched the literature for controlled trials of IV or IM NAD+ for anti-aging or wellness purposes and found none eligible [P6]. Not a small number. None.
That doesn’t mean nobody ever feels different after a drip. It means there’s no controlled evidence that the infusion itself produces the effect, as opposed to sitting quietly for an hour, hydration, or plain expectation. A premium price tag attached to a same-day promise isn’t backed by the research, and it’s worth treating that gap seriously before paying it.
So how long should someone actually wait before judging it?
Since the human studies ran for weeks rather than days, a couple of months is a more sensible window than a couple of doses. But patience should come paired with honesty: if a sensible trial period ends and nothing has changed, that’s real information, not a signal to raise the dose and try again. There’s no human-outcome evidence that pushing well past the studied 250 mg per day for NMN [P1] produces a bigger effect. Escalating the dose mostly means spending more for the same uncertainty.
The single most useful habit here is unglamorous: write it down. Energy, sleep, mood, any side effects, tracked over those weeks. Because the evidence base is thin, a personal log is genuinely one of the better signals available. Working with a clinician turns that log into something concrete two people can look at together, rather than a vague impression one person is trying to trust.
Providers such as FormBlends offer access to these compounds through a physician consultation and prescription, with dispensing handled by a licensed compounding pharmacy. One honest reason that supervision helps is exactly this: someone qualified can look at the actual record and help decide whether continuing makes sense.
A recent legal wrinkle worth knowing about
NMN’s status as a US supplement moved around for years, and it changed again recently. In letters dated September 29, 2025, the FDA concluded that NMN is not excluded from the dietary-supplement definition, reversing its earlier position and citing evidence that NMN was sold as a supplement before drug authorization [P7]. As of 2026, NMN can lawfully be bought as a supplement in the US. Lawful to buy is not the same as proven to work, or verified for what’s actually in the bottle, and since the ruling is recent, it’s worth checking the current FDA wording directly.
Putting the three clocks together
Don’t expect much in the first week or two, and don’t treat that as failure, because it’s the normal starting point while the marker clock does its slow work. The felt-experience clock, if it moves at all, showed up over multiple weeks in the actual trials, and what moved was specific and lab-measured [P1][P2], not a guaranteed feeling. The marketing clock, particularly around IV drips, has no controlled trials behind it at all [P6], so same-day promises deserve real skepticism. Give a sensible plan a couple of months, track how the body actually responds, and let that record, ideally reviewed with a clinician, guide the decision to continue. Neither compound is a proven fountain of youth [P4]. Going in with clear expectations protects both health decisions and the wallet.
What people usually want to know
How long does NAD+ or NMN take to work? Think in weeks, not days. The strongest human trial ran ten weeks, with postmenopausal prediabetic women taking 250 mg of NMN daily before a measurable change in muscle insulin sensitivity appeared [1]. Lab markers like NAD+ levels can start rising within the first couple of weeks of an oral precursor [3], but that marker moving is not the same as noticing anything.
Will there actually be a feeling of change? Possibly not in any obvious way. The proven human effects so far are lab-measured, like improved muscle insulin sensitivity [1], not a noticeable energy surge. In amateur runners, some narrow aerobic markers improved while VO2max stayed the same, meaning they likely wouldn’t have felt a clear difference [2]. Feeling better is worth tracking. Feeling nothing distinct doesn’t mean anything is being done wrong.
Do NAD+ IV drips work faster than oral NMN? There’s no controlled evidence they work at all for anti-aging or wellness purposes. A 2026 systematic review searched the literature and found no eligible controlled outcomes trials of IV or IM NAD+ for these uses [6]. Any same-day feeling could just as easily be hydration, rest, or expectation, so premium pricing built on a reliable-result promise isn’t supported.
Is more than 250 mg of NMN per day better? No human-outcome evidence supports that. The dose that produced a measurable effect in the strongest trial was 250 mg per day [1], and nothing shows that going well past that produces a bigger result. If a sensible trial period ends with no noticeable change, that’s real information, not a reason to keep raising the dose.
Does NAD+ or NMN actually slow aging or extend lifespan? That remains unproven in humans. NAD+ does decline steadily with age in human tissue [5], which is the genuine observation behind this whole category, but a major review of NAD+ biology states plainly that whether restoring it in aging humans helps is still unknown [4]. Realistic expectations matter more here than any promotional claim.
Is NMN legal to buy in the US? Yes, as of 2026 it can be lawfully purchased as a dietary supplement. In letters dated September 29, 2025, the FDA concluded that NMN is not excluded from the supplement definition, reversing its earlier stance [7]. Lawful to buy is not the same as proven to work or verified for label accuracy, and since this is a recent ruling, checking the current FDA wording directly is worthwhile.
Is NAD+ itself a better starting point than NMN?
NMN is generally the more practical entry point for most people. NAD+ molecules are large and tend to break down in the gut before reaching cells, while NMN is smaller and absorbed more efficiently into the bloodstream. That said, no definitive human clinical trial crowns one option the clear winner, so the honest answer is that the science hasn’t caught up to the marketing yet.
How long before someone notices anything at all?
People who do report noticeable changes tend to mention better sleep or slightly steadier energy within the first two to four weeks. Any sense of mental clarity, if it appears, tends to show up closer to six to eight weeks. Some people notice nothing distinct for months. Individual variation is real, and placebo effect is genuinely hard to rule out without a controlled comparison, so tracking a specific metric before starting is a good idea.
What dose do most people actually use, and does more mean better results?
Most self-reported protocols land between 250 mg and 500 mg daily, often taken in the morning since NAD+ pathways connect to circadian signaling. Higher doses, some researchers have tested as much as 1,200 mg, haven’t shown obvious harm in short trials, but there’s no good evidence that doubling the dose doubles the benefit. Starting low and adjusting slowly is the sensible approach.
Does it matter whether NMN comes from a supplement brand or a compounding pharmacy?
Yes, more than most buyers realize. Supplement brands aren’t required to verify purity or potency before selling a product. A compounding pharmacy operating under physician supervision, such as FormBlends, works within a regulated framework that includes quality testing and medical oversight, which means there’s actual accountability if something is off. For anyone taking NMN for a specific health reason rather than general curiosity, that accountability gap deserves real weight.
References
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Liao B, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. J Int Soc Sports Nutr. 2021. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018.
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021.
- Massudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012.
- Systematic review of NAD+ and precursor supplementation for ageing outcomes. Ageing Res Rev. 2026.
- US Food and Drug Administration. Conclusion that NMN is not excluded from the dietary supplement definition (letters dated September 29, 2025).
Sources: NMN 250 mg/day and muscle insulin sensitivity in prediabetic women, Science 2021, [P1]. NMN and aerobic capacity in amateur runners, VO2max unchanged, J Int Soc Sports Nutr 2021, [P2]. Nicotinamide riboside well tolerated, raises NAD+ over weeks in middle-aged and older adults, Nat Commun 2018, [P3]. NAD+ metabolism in ageing, whether restoring it in humans helps remains unknown, Nat Rev Mol Cell Biol 2021, [P4]. Age-associated NAD+ decline in human tissue, PLoS One 2012, [P5]. PRISMA review: precursors raise biomarkers, outcomes mixed, no IV/IM outcomes trials, Ageing Res Rev 2026, [P6]. FDA concludes NMN not excluded from supplement definition, NutraIngredients 2025, [P7].
